Can You Really Do Chemisty Experiments About 492-27-3

Although many compounds look similar to this compound(492-27-3)Related Products of 492-27-3, numerous studies have shown that this compound(SMILES:O=C(C1=NC2=CC=CC=C2C(O)=C1)O), has unique advantages. If you want to know more about similar compounds, you can read my other articles.

Related Products of 492-27-3. The protonation of heteroatoms in aromatic heterocycles can be divided into two categories: lone pairs of electrons are in the aromatic ring conjugated system; and lone pairs of electrons do not participate. Compound: 4-Hydroxyquinoline-2-carboxylic Acid, is researched, Molecular C10H7NO3, CAS is 492-27-3, about The role of tryptophan metabolic pathway in children with attention deficit hyperactivity disorder with and without comorbid oppositional defiant disorder and conduct disorder. Author is Saglam, Ebru; Bilgic, Ayhan; Abusoglu, Sedat; Unlu, Ali; Sivrikaya, Abdullah.

Accumulating data presented that tryptophan metabolic pathway (TMP) may play a role in attention-deficit/hyperactivity disorder (ADHD). However, no study have investigated potential role of TMP in disruptive behavior disorders coexisting with ADHD. This study compared serum levels of tryptophan, kynurenine, kynurenic acid, 3-hydroxykynurenine and 3-hydroxyantranilic acid in medication-free children with ADHD combined presentation (ADHD-C), with ADHD-C and oppositional defiant disorder (ODD), and with ADHD-C and conduct disorder (CD) vs. healthy controls. The study also compared several ratios that are previously suggested to reflect the activities of the KP enzymes (kynurenine/tryptophan, kynurenic acid/kynurenine, 3-hydroxykynurenine/kynurenine) or neuroprotective activity (kynurenic acid/3-hydroxykynurenine) among groups. A total of 122 patients were enrolled: 46 children with ADHD-C alone, 43 children with ADHD-C+ODD, 33 children with ADHD-C+CD and 50 healthy controls. Targeted biochem. mols. were assessed by liquid chromatog.-mass spectrometry/mass spectrometry. Compared to control group, serum kynurenine levels were significantly higher in the ADHD-C group, serum 3-hydroxykynurenine levels were significantly lower in the ADHD-C and ADHD-C+ODD groups, the serum kynurenic acid/kynurenine ratio was significantly higher in the ADHD-C, ADHD-C+ODD and ADHD-C+CD groups, and the serum 3-hydroxykynurenine/kynurenine ratio was significantly lower in the ADHD-C group. These findings suggest that TMP may play a role in the pathophysiol. of ADHD-C.

Although many compounds look similar to this compound(492-27-3)Related Products of 492-27-3, numerous studies have shown that this compound(SMILES:O=C(C1=NC2=CC=CC=C2C(O)=C1)O), has unique advantages. If you want to know more about similar compounds, you can read my other articles.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”

 

Some scientific research about 492-27-3

Although many compounds look similar to this compound(492-27-3)Computed Properties of C10H7NO3, numerous studies have shown that this compound(SMILES:O=C(C1=NC2=CC=CC=C2C(O)=C1)O), has unique advantages. If you want to know more about similar compounds, you can read my other articles.

Most of the compounds have physiologically active properties, and their biological properties are often attributed to the heteroatoms contained in their molecules, and most of these heteroatoms also appear in cyclic structures. A Journal, Article, Research Support, Non-U.S. Gov’t, Journal of Hazardous Materials called Uranium(VI) bioassociation by different fungi – a comparative study into molecular processes, Author is Wollenberg, Anne; Kretzschmar, Jerome; Drobot, Bjoern; Huebner, Rene; Freitag, Leander; Lehmann, Falk; Guenther, Alix; Stumpf, Thorsten; Raff, Johannes, which mentions a compound: 492-27-3, SMILESS is O=C(C1=NC2=CC=CC=C2C(O)=C1)O, Molecular C10H7NO3, Computed Properties of C10H7NO3.

After the Chernobyl and Fukushima incidents it has become clear that fungi can take up and accumulate large quantities of radionuclides and heavy metals, but the underlying processes are not well understood yet. For this study, the mol. interactions of uranium(VI) with the white-rot fungi, Schizophyllum commune and Pleurotus ostreatus, and the soil-living fungus, Leucoagaricus naucinus, were investigated. First, the uranium concentration in the biomass was determined by time-dependent bioassocn. experiments To characterize the mol. interactions, uranium was localized in the biomass by transmission electron microscopy anal. Second, the formed uranyl complexes in both biomass and supernatant were determined by fluorescence spectroscopy. Addnl., possible bioligands in the supernatant were identified. The results show that the discernible interactions between metals and fungi are similar, namely biosorption, accumulation, and subsequent crystallization But at the same time, the underlying biochem. mechanisms are different and specific to the fungal species. In addition, Schizophyllum commune was found to be the only fungus that, under the chosen exptl. conditions, released tryptophan and other indole derivatives in the presence of uranium(VI) as determined by NMR spectroscopy. These released substances most likely act as messenger mols. rather than serving the direct detoxification of uranium(VI).

Although many compounds look similar to this compound(492-27-3)Computed Properties of C10H7NO3, numerous studies have shown that this compound(SMILES:O=C(C1=NC2=CC=CC=C2C(O)=C1)O), has unique advantages. If you want to know more about similar compounds, you can read my other articles.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”

 

Let`s talk about compounds: 492-27-3

Compounds in my other articles are similar to this one(4-Hydroxyquinoline-2-carboxylic Acid)Related Products of 492-27-3, you can compare them to see their pros and cons in some ways,such as convenient, effective and so on.

So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic.Chen, Li-Ming; Bao, Chun-Hui; Wu, Yu; Liang, Shi-Hua; Wang, Di; Wu, Lu-Yi; Huang, Yan; Liu, Hui-Rong; Wu, Huan-Gan researched the compound: 4-Hydroxyquinoline-2-carboxylic Acid( cas:492-27-3 ).Related Products of 492-27-3.They published the article 《Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease》 about this compound( cas:492-27-3 ) in Journal of Neuroinflammation. Keywords: review inflammatory bowel disease depression gut brain tryptophan kynurenine; Depression; IDO; Inflammatory bowel disease; The brain-gut axis; Tryptophan-kynurenine metabolic pathway. We’ll tell you more about this compound (cas:492-27-3).

A review. Inflammatory bowel disease (IBD), which mainly includes ulcerative colitis (UC) and Crohn’s disease (CD), is a group of chronic bowel diseases that are characterized by abdominal pain, diarrhea, and bloody stools. IBD is strongly associated with depression, and its patients have a higher incidence of depression than the general population. Depression also adversely affects the quality of life and disease prognosis of patients with IBD. The tryptophan-kynurenine metabolic pathway degrades more than 90% of tryptophan (TRP) throughout the body, with indoleamine 2,3-dioxygenase (IDO), the key metabolic enzyme, being activated in the inflammatory environment. A series of metabolites of the pathway are neurol. active, among which kynerunic acid (KYNA) and quinolinic acid (QUIN) are mols. of great interest in recent studies on the mechanisms of inflammation-induced depression. In this , the relationship between depression in IBD and the tryptophan-kynurenine metabolic pathway is overviewed in the light of recent publications.

Compounds in my other articles are similar to this one(4-Hydroxyquinoline-2-carboxylic Acid)Related Products of 492-27-3, you can compare them to see their pros and cons in some ways,such as convenient, effective and so on.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”

 

The origin of a common compound about 492-27-3

Compounds in my other articles are similar to this one(4-Hydroxyquinoline-2-carboxylic Acid)Computed Properties of C10H7NO3, you can compare them to see their pros and cons in some ways,such as convenient, effective and so on.

Computed Properties of C10H7NO3. The mechanism of aromatic electrophilic substitution of aromatic heterocycles is consistent with that of benzene. Compound: 4-Hydroxyquinoline-2-carboxylic Acid, is researched, Molecular C10H7NO3, CAS is 492-27-3, about Increased serum QUIN/KYNA is a reliable biomarker of post-stroke cognitive decline. Author is Cogo, Adrien; Mangin, Gabrielle; Maier, Benjamin; Callebert, Jacques; Mazighi, Mikael; Chabriat, Hughes; Launay, Jean-Marie; Huberfeld, Gilles; Kubis, Nathalie.

Strokes are becoming less severe due to increased numbers of intensive care units and improved treatments. As patients survive longer, post-stroke cognitive impairment (PSCI) has become a major health public issue. Diabetes has been identified as an independent predictive factor for PSCI. Here, we characterized a clin. relevant mouse model of PSCI, induced by permanent cerebral artery occlusion in diabetic mice, and investigated whether a reliable biomarker of PSCI may emerge from the kynurenine pathway which has been linked to inflammatory processes. Cortical infarct was induced by permanent middle cerebral artery occlusion in male diabetic mice (streptozotocin IP). Six weeks later, cognitive assessment was performed using the Barnes maze, hippocampi long-term potentiation using microelectrodes array recordings, and neuronal death, white matter rarefaction and microglia/macrophages d. assessed in both hemispheres using imunohistochem. Brain and serum metabolites of the kynurenin pathway were measured using HPLC and mass fragmentog. At last, these same metabolites were measured in the patients serum, at the acute phase of stroke, to determine if they could predict PSCI 3 mo later. We found long-term spatial memory was impaired in diabetic mice 6 wk after stroke induction. Synaptic plasticity was completely suppressed in both hippocampi along with increased neuronal death, white matter rarefaction in both striatum, and increased microglial/macrophage d. in the ipsilateral hemisphere. Brain and serum quinolinic acid concentrations and quinolinic acid over kynurenic acid ratios were significantly increased compared to control, diabetic and non-diabetic ischemic mice, where PSCI was absent. These putative serum biomarkers were strongly correlated with degradation of long-term memory, neuronal death, microglia/macrophage infiltration and white matter rarefaction. Moreover, we identified these same serum biomarkers as potential predictors of PSCI in a pilot study of stroke patients. We have established and characterized a new model of PSCI, functionally and structurally, and we have shown that the QUIN/KYNA ratio could be used as a surrogate biomarker of PSCI, which may now be tested in large prospective studies of stroke patients.

Compounds in my other articles are similar to this one(4-Hydroxyquinoline-2-carboxylic Acid)Computed Properties of C10H7NO3, you can compare them to see their pros and cons in some ways,such as convenient, effective and so on.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”

 

Something interesting about 492-27-3

Compounds in my other articles are similar to this one(4-Hydroxyquinoline-2-carboxylic Acid)SDS of cas: 492-27-3, you can compare them to see their pros and cons in some ways,such as convenient, effective and so on.

Epoxy compounds usually have stronger nucleophilic ability, because the alkyl group on the oxygen atom makes the bond angle smaller, which makes the lone pair of electrons react more dissimilarly with the electron-deficient system. Compound: 4-Hydroxyquinoline-2-carboxylic Acid, is researched, Molecular C10H7NO3, CAS is 492-27-3, about Evidence that a deviation in the kynurenine pathway aggravates atherosclerotic disease in humans.SDS of cas: 492-27-3.

Objectives : In this study, we performed a multiplatform anal. of tissue samples, in vitro and in vivo functional assays to elucidate the potential role of the kynurenine pathway in human atherosclerosis. Methods and results : Comparison of transcriptomic data from carotid plaques and control arteries revealed an upregulation of enzymes within the quinolinic branch of the kynurenine pathway in the disease state, while the branch leading to the formation of kynurenic acid (KynA) was downregulated. Further analyses indicated that local inflammatory responses are closely tied to the deviation of the kynurenine pathway in the vascular wall. Anal. of cerebrovascular symptomatic and asymptomatic carotid stenosis data showed that the downregulation of KynA branch enzymes and reduced KynA production were associated with an increased probability of patients to undergo surgery due to an unstable disease. In vitro, we showed that KynA-mediated signalling through aryl hydrocarbon receptor (AhR) is a major regulator of human macrophage activation. Using a mouse model of peritoneal inflammation, we showed that KynA inhibits leukocyte recruitment. Conclusions : We have found that a deviation in the kynurenine pathway is associated with an increased probability of developing symptomatic unstable atherosclerotic disease. Our study suggests that KynA-mediated signalling through AhR is an important mechanism involved in the regulation of vascular inflammation.

Compounds in my other articles are similar to this one(4-Hydroxyquinoline-2-carboxylic Acid)SDS of cas: 492-27-3, you can compare them to see their pros and cons in some ways,such as convenient, effective and so on.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”

 

Application of 492-27-3

Although many compounds look similar to this compound(492-27-3)Product Details of 492-27-3, numerous studies have shown that this compound(SMILES:O=C(C1=NC2=CC=CC=C2C(O)=C1)O), has unique advantages. If you want to know more about similar compounds, you can read my other articles.

In general, if the atoms that make up the ring contain heteroatoms, such rings become heterocycles, and organic compounds containing heterocycles are called heterocyclic compounds. An article called Effect of a single bout of aerobic exercise on kynurenine pathway metabolites and inflammatory markers in prostate cancer patients-a pilot randomized controlled trial, published in 2021, which mentions a compound: 492-27-3, Name is 4-Hydroxyquinoline-2-carboxylic Acid, Molecular C10H7NO3, Product Details of 492-27-3.

The kynurenine (KYN) pathway gains growing research interest concerning the genesis, progression and therapy of solid tumors. Previous studies showed exercise-induced effects on metabolite levels along the KYN pathway. Modulations of the KYN pathway might be involved in the pos. impact of exercise on prostate cancer progression and mortality. The objective of this trial was to investigate whether a single-phys. exercise alters tryptophan (TRP) metabolism and related inflammatory markers in this population. We conducted a randomized controlled trial with 24 patients suffering from prostate cancer. While the control group remained inactive, the intervention group performed a 30-min aerobic exercise on a bicycle ergometer at 75% of individual VO2peak. Before (t0) and directly after the exercise intervention (t1) KYN, TRP, kynurenic acid, quinolinic acid as well as various inflammation markers (IL6, TNF-α, TGF-β) were measured in blood serum. At baseline, the present sample showed robust correlations between TRP, KYN, quinolinic acid and inflammatory markers. Regarding the exercise intervention, interaction effects for TRP, the KYN/TRP ratio and TGF-β were observed The results show for the first time that acute phys. exercise impacts TRP metabolism in prostate cancer patients. Moreover, baseline associations underline the relationship between inflammation and the KYN pathway in prostate cancer.

Although many compounds look similar to this compound(492-27-3)Product Details of 492-27-3, numerous studies have shown that this compound(SMILES:O=C(C1=NC2=CC=CC=C2C(O)=C1)O), has unique advantages. If you want to know more about similar compounds, you can read my other articles.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”

 

The Absolute Best Science Experiment for 492-27-3

Compounds in my other articles are similar to this one(4-Hydroxyquinoline-2-carboxylic Acid)Recommanded Product: 492-27-3, you can compare them to see their pros and cons in some ways,such as convenient, effective and so on.

Epoxy compounds usually have stronger nucleophilic ability, because the alkyl group on the oxygen atom makes the bond angle smaller, which makes the lone pair of electrons react more dissimilarly with the electron-deficient system. Compound: 4-Hydroxyquinoline-2-carboxylic Acid, is researched, Molecular C10H7NO3, CAS is 492-27-3, about Kynurenic acid and its analogue SZR-72 ameliorate the severity of experimental acute necrotizing pancreatitis.Recommanded Product: 492-27-3.

The pathophysiol. of acute pancreatitis (AP) is not well understood, and the disease does not have specific therapy. Tryptophan metabolite L-kynurenic acid (KYNA) and its synthetic analog SZR-72 are antagonists of the N-methyl-D-aspartate receptor (NMDAR) and have immune modulatory roles in several inflammatory diseases. Our aims were to investigate the effects of KYNA and SZR-72 on exptl. AP and to reveal their possible mode of action. AP was induced by i.p. (i.p.) injection of L-ornithine-HCl (LO) in SPRD rats. Animals were pretreated with 75-300 mg/kg KYNA or SZR-72. Control animals were injected with physiol. saline instead of LO, KYNA and/ or SZR-72. Laboratory and histol. parameters, as well as pancreatic and systemic circulation were measured to evaluate AP severity. Pancreatic heat shock protein-72 and IL-1b were measured by western blot and ELISA, resp. Pancreatic expression of NMDAR1 was investigated by RT-PCR and immunohistochem. Viability of isolated pancreatic acinar cells in response to LO, KYNA, SZR-72 and/or NMDA administration was assessed by propidium-iodide assay. The effects of LO and/or SZR-72 on neutrophil granulocyte function was also studied. Almost all investigated laboratory and histol. parameters of AP were significantly reduced by administration of 300 mg/kg KYNA or SZR-72, whereas the 150 mg/kg or 75 mg/kg doses were less or not effective, resp. The decreased pancreatic microcirculation was also improved in the AP groups treated with 300 mg/kg KYNA or SZR-72. Interestingly, pancreatic heat shock protein-72 expression was significantly increased by administration of SZR-72, KYNA and/or LO. mRNA and protein expression of NMDAR1 was detected in pancreatic tissue. LO treatment caused acinar cell toxicity which was reversed by 250μM KYNA or SZR-72. Treatment of acini with NMDA (25, 250, 2000μM) did not influence the effects of KYNA or SZR-72. Moreover, SZR-72 reduced LO-induced H2O2 production of neutrophil granulocytes. KYNA and SZR-72 have dose-dependent protective effects on LOinduced AP or acinar toxicity which seem to be independent of pancreatic NMDA receptors. Furthermore, SZR-72 treatment suppressed AP-induced activation of neutrophil granulocytes. This study suggests that administration of KYNA and its derivative could be beneficial in AP.

Compounds in my other articles are similar to this one(4-Hydroxyquinoline-2-carboxylic Acid)Recommanded Product: 492-27-3, you can compare them to see their pros and cons in some ways,such as convenient, effective and so on.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”

 

The influence of catalyst in reaction 492-27-3

Although many compounds look similar to this compound(492-27-3)HPLC of Formula: 492-27-3, numerous studies have shown that this compound(SMILES:O=C(C1=NC2=CC=CC=C2C(O)=C1)O), has unique advantages. If you want to know more about similar compounds, you can read my other articles.

The chemical properties of alicyclic heterocycles are similar to those of the corresponding chain compounds. Compound: 4-Hydroxyquinoline-2-carboxylic Acid, is researched, Molecular C10H7NO3, CAS is 492-27-3, about A narrative review of the roles of indoleamine 2,3-dioxygenase and tryptophan-2,3-dioxygenase in liver diseases, the main research direction is review IDO TDO viral hepatitis liver disease cancer; Indoleamine 2,3-dioxygenase (IDO); autoimmune liver diseases; liver fibrosis and cirrhosis; liver tumors; viral hepatitis.HPLC of Formula: 492-27-3.

A review. Indoleamine 2,3-dioxygenase (IDO) and tryptophan-2,3-dioxygenase (TDO) are induced by several immune factors, such as interferon-γ, and act as intracellular enzymes that catabolize essential amino acid tryptophan into kynurenine and other downstream metabolites, including kynurenic acid (KYNA), xanthurenic acid (XA) and so on. IDO and TDO work as a double-edge sword. On one hand, they exert the immunomodulatory effects, especially immunosuppressive effects on the microenvironment including infections, pregnancy, tumor cells escape and transplantation. TDO plays the major role under basal conditions, while IDO comes into play under different circumstances of immune activation, thus IDO has a wider spectrum of immune regulation. On the other hand, these enzymes also inhibit pathogens such as Chlamydia pneumoniae, Staphylococcus aureus, Toxoplasma gondii and so on. Moreover, IDO regulates metabolic health through shaping intestinal microbiota. Recently, these enzymes have attracted more and more attention in liver diseases. Several studies have indicated that IDO and TDO can modulate viral hepatitis, autoimmune liver diseases, non-alc. fatty liver disease (NAFLD), liver cirrhosis, liver cancer even liver transplantation. Targeting them or their antagonists may provide novel therapeutic treatments for liver diseases. In this review, we will discuss the exact roles that IDO and TDO play in diverse hepatic diseases.

Although many compounds look similar to this compound(492-27-3)HPLC of Formula: 492-27-3, numerous studies have shown that this compound(SMILES:O=C(C1=NC2=CC=CC=C2C(O)=C1)O), has unique advantages. If you want to know more about similar compounds, you can read my other articles.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”

 

New learning discoveries about 492-27-3

Compounds in my other articles are similar to this one(4-Hydroxyquinoline-2-carboxylic Acid)Application of 492-27-3, you can compare them to see their pros and cons in some ways,such as convenient, effective and so on.

Application of 492-27-3. The fused heterocycle is formed by combining a benzene ring with a single heterocycle, or two or more single heterocycles. Compound: 4-Hydroxyquinoline-2-carboxylic Acid, is researched, Molecular C10H7NO3, CAS is 492-27-3, about Prenatal Kynurenine Elevation Elicits Sex-Dependent Changes in Sleep and Arousal During Adulthood: Implications for Psychotic Disorders.. Author is Rentschler, Katherine M; Baratta, Annalisa M; Ditty, Audrey L; Wagner, Nathan T J; Wright, Courtney J; Milosavljevic, Snezana; Mong, Jessica A; Pocivavsek, Ana.

Dysregulation of the kynurenine pathway (KP) of tryptophan catabolism has been implicated in psychotic disorders, including schizophrenia and bipolar disorder. Kynurenic acid (KYNA) is a KP metabolite synthesized by kynurenine aminotransferases (KATs) from its biological precursor kynurenine and acts as an endogenous antagonist of N-methyl-D-aspartate and α7-nicotinic acetylcholine receptors. Elevated KYNA levels found in postmortem brain tissue and cerebrospinal fluid of patients are hypothesized to play a key role in the etiology of cognitive symptoms observed in psychotic disorders. Sleep plays an important role in memory consolidation, and sleep disturbances are common among patients. Yet, little is known about the effect of altered KP metabolism on sleep-wake behavior. We presently utilized a well-established experimental paradigm of embryonic kynurenine (EKyn) exposure wherein pregnant dams are fed a diet laced with kynurenine the last week of gestation and hypothesized disrupted sleep-wake behavior in adult offspring. We examined sleep behavior in adult male and female offspring using electroencephalogram and electromyogram telemetry and determined sex differences in sleep and arousal in EKyn offspring. EKyn males displayed reduced rapid eye movement sleep, while female EKyn offspring were hyperaroused compared to controls. We determined that EKyn males maintain elevated brain KYNA levels, while KYNA levels were unchanged in EKyn females, yet the activity levels of KAT I and KAT II were reduced. Our findings indicate that elevated prenatal kynurenine exposure elicits sex-specific changes in sleep-wake behavior, arousal, and KP metabolism.

Compounds in my other articles are similar to this one(4-Hydroxyquinoline-2-carboxylic Acid)Application of 492-27-3, you can compare them to see their pros and cons in some ways,such as convenient, effective and so on.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”

 

Application of 492-27-3

As far as I know, this compound(492-27-3)Reference of 4-Hydroxyquinoline-2-carboxylic Acid can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Most of the natural products isolated at present are heterocyclic compounds, so heterocyclic compounds occupy an important position in the research of organic chemistry. A compound: 492-27-3, is researched, SMILESS is O=C(C1=NC2=CC=CC=C2C(O)=C1)O, Molecular C10H7NO3Journal, Article, Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology called Kynurenic Acid Protects Against Reactive Glial-associated Reductions in the Complexity of Primary Cortical Neurons., Author is O’Reilly, Kate; O’Farrell, Katherine; Midttun, Oivind; Rakovets, Yuliia; David-Bercholz, Jennifer; Harkin, Andrew, the main research direction is Glia; Kynurenic acid; Kynurenine pathway; Primary cortical neurons.Reference of 4-Hydroxyquinoline-2-carboxylic Acid.

Brain glia produce neuroactive metabolites via tryptophan-kynurenine catabolism. A role for kynurenine pathway (KP) metabolites is proposed in reactive glial associated neurodegeneration. The aim of this investigation was to assess the role of KP induction and KP metabolites in driving reactive glial associated neuronal atrophy. Rat primary mixed glia, and enriched microglial and astroglial cultures were stimulated with IFNγ (10 ng/ml) for 24 hours. KP induction in mixed glial cells was confirmed by raised expression of the rate limiting KP enzyme indoleamine 2,3 dioxygenase (IDO) and raised concentrations of KP metabolites kynurenic acid (KYNA) and quinolinic acid (QUIN) in the conditioned media. Conditioned media was transferred onto immature (3 days) and mature (21 days) primary cortical neurons in vitro for 24 hours. IFNγ-stimulated mixed glial conditioned media reduced neurite outgrowth and complexity of both immature and mature neurons and co-localised expression of synaptic markers determined by immunocytochemistry. Pre-treatment of mixed glial cells with the IDO inhibitor, 1-methyltryptophan (1-MT) (L) prevented these effects of IFNγ-stimulated mixed glial conditioned media. KYNA increased complexity and synapse formation in mature cortical neurons and protected against reduced neuronal complexity and co-localised expression of synaptic markers induced by conditioned media from IFNγ-stimulated mixed glia and by treatment of neuronal cells with QUIN (1 µM). Overall, this study supports a role for the KP in driving neuronal atrophy associated with reactive glia and indicates that inhibition of the KP in glia, or raising the concentration of the astrocytic metabolite KYNA, protects against reactive microglial and QUIN-associated neuronal atrophy.

As far as I know, this compound(492-27-3)Reference of 4-Hydroxyquinoline-2-carboxylic Acid can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”